We are live on ! Find out more
SILK

Silk Road Medical, Inc. Common Stock

Delisted

SILK was delisted on the 16th of September, 2024.

130 hedge funds and large institutions have $1.18B invested in Silk Road Medical, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 10

247% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 17

116% more call options, than puts

Call options by funds: $2.05M | Put options by funds: $948K

37% more capital invested

Capital invested by funds: $859M → $1.18B (+$322M)

29% more funds holding

Funds holding: 101130 (+29)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
130
Holders Change
+29
Holders Change %
+28.71%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
44
Increased
59
Reduced
17
Closed
10
Calls
$2.05M
Puts
$948K
Net Calls
+$1.1M
Net Calls Change
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
WP
1
Warburg Pincus
New York
$238M -$52.5M -1,500,000 -20%
Wells Fargo
2
Wells Fargo
California
$94.1M +$43.9M +1,253,220 +116%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$77.9M -$32.1M -916,653 -32%
Vanguard Group
4
Vanguard Group
Pennsylvania
$61.8M +$20.1M +574,793 +60%
AllianceBernstein
5
AllianceBernstein
Tennessee
$59M +$15.2M +433,416 +42%
BlackRock
6
BlackRock
New York
$56.4M +$15.6M +445,975 +47%
BAMCO Inc
7
BAMCO Inc
New York
$55M +$4.58M +130,749 +11%
DM
8
Deerfield Management
New York
$51.7M +$10.5M +300,000 +31%
Jennison Associates
9
Jennison Associates
New York
$49.5M +$6.37M +181,977 +17%
TCM
10
TimesSquare Capital Management
New York
$39.3M +$13M +371,560 +62%
Victory Capital Management
11
Victory Capital Management
Texas
$30.7M +$2.42M +69,051 +10%
SPPAM
12
Summit Partners Public Asset Management
Massachusetts
$25.7M +$9.46M +270,319 +74%
WA
13
Wasatch Advisors
Utah
$17.8M +$14.2M +405,656 +1,136%
PCM
14
Peregrine Capital Management
Minnesota
$17.8M +$15.4M +440,097 New
NCGI
15
Next Century Growth Investors
Minnesota
$17.2M +$12.6M +359,574 +551%
ClearBridge Investments
16
ClearBridge Investments
New York
$16.9M +$14.7M +419,856 New
Massachusetts Financial Services
17
Massachusetts Financial Services
Massachusetts
$16.2M +$4.44M +126,700 +46%
American Century Companies
18
American Century Companies
Missouri
$13.6M +$4.4M +125,711 +60%
Invesco
19
Invesco
Georgia
$13M -$105K -3,005 -0.9%
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$12.7M +$3.33M +95,235 +44%
Lord, Abbett & Co
21
Lord, Abbett & Co
New Jersey
$12.6M -$2.07M -59,240 -16%
CC
22
Cannell & Co
New York
$12.1M +$10.5M +300,646 New
State Street
23
State Street
Massachusetts
$11.3M +$3.24M +92,586 +49%
NHAS
24
Novo Holdings A/S
Denmark
$9.89M
Kayne Anderson Rudnick Investment Management
25
Kayne Anderson Rudnick Investment Management
California
$9.07M +$1.03M +29,347 +15%

SILK Hedge Fund Activity: Q4 2019 in Review

130 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q4 2019, worth a combined $1.18B — up 37% from $859M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new SILK positions and 10 closed out — a net gain of 34 holders — while 59 added to existing stakes and 17 trimmed.

The largest buyer was Wells Fargo, adding an estimated $43.9M. The largest seller was Warburg Pincus, cutting an estimated $52.5M.

  • 130 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q4 2019, up from 101 in Q3 2019.
  • Funds reported $1.18B of Silk Road Medical, Inc. Common Stock stock for Q4 2019, up 37% quarter-over-quarter.
  • 44 funds opened new Silk Road Medical, Inc. Common Stock positions in Q4 2019 and 10 closed out, a net change of +34 holders.
  • The largest Silk Road Medical, Inc. Common Stock buyer in Q4 2019 was Wells Fargo, an estimated $43.9M added.
  • The largest Silk Road Medical, Inc. Common Stock seller in Q4 2019 was Warburg Pincus, an estimated $52.5M sold.

Based on aggregated 13F filings for Q4 2019.